关于 Genosco

关于公司

Founded in 2008, Genosco is a clinical-stage biotechnology company pursuing the discovery and development of novel small-molecule drugs to treat patients with unmet medical needs.They utilize a highly targeted approach with expertise in selective kinase inhibitors. Currently, they have discovered several master scaffolds selectively inhibiting protein kinases which are enzymes that transfer phosphate groups to proteins and are key players in virtually all signal pathways.